Compare Lime Chemicals with Similar Stocks
Dashboard
With a Operating Losses, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Net Sales has grown by an annual rate of -23.06% and Operating profit at -187.74% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at 3.92 times
Flat results in Dec 25
Risky - Negative EBITDA
Underperformed the market in the last 1 year
Stock DNA
Commodity Chemicals
INR 9 Cr (Micro Cap)
NA (Loss Making)
37
0.00%
2.67
-8.33%
4.73
Total Returns (Price + Dividend) 
Latest dividend: 0.9700 per share ex-dividend date: Sep-25-2006
Risk Adjusted Returns v/s 
Returns Beta
News

Lime Chemicals Ltd Downgraded to Strong Sell Amid Weak Fundamentals and Bearish Technicals
Lime Chemicals Ltd has been downgraded from a Sell to a Strong Sell rating as of 6 March 2026, reflecting deteriorating fundamentals, challenging valuation metrics, a weakening financial trend, and increasingly bearish technical indicators. The commodity chemicals company’s current market cap grade remains low at 4, with a Mojo Score of 17.0, signalling significant caution for investors amid a 10% drop in share price on the downgrade day.
Read full news article
Lime Chemicals Ltd Upgraded to Sell on Technical Improvements Despite Weak Fundamentals
Lime Chemicals Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 4 March 2026, driven primarily by a shift in technical indicators signalling a mildly bullish trend. Despite this upgrade, the company continues to face significant challenges in its financial performance and valuation metrics, reflecting a cautious outlook for investors in the commodity chemicals sector.
Read full news article
Lime Chemicals Q3 FY26: Losses Deepen as Revenue Decline Continues
Lime Chemicals Ltd., a micro-cap commodity chemicals manufacturer with a market capitalisation of ₹8.46 crores, reported a net loss of ₹0.08 crores for Q3 FY26 (October-December 2025), marking the second consecutive quarter of losses. The company's revenue declined 41.15% year-on-year to ₹1.53 crores, whilst operating margins remained deeply negative at -5.88%, reflecting severe operational distress in the calcium carbonate manufacturing segment.
Read full news article Announcements 
Announcement under Regulation 30 (LODR)-Change in Registered Office Address
13-Mar-2026 | Source : BSERefer attached document.
Board Meeting Outcome for Outcome Of The Board Meeting Held On Friday 13Th March 2026
13-Mar-2026 | Source : BSERefer attached document
Announcement under Regulation 30 (LODR)-Change in Management
13-Mar-2026 | Source : BSERefer attached document
Corporate Actions 
No Upcoming Board Meetings
Lime Chemicals Ltd has declared 12% dividend, ex-date: 25 Sep 06
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Non Institution
None
Held by 5 Schemes (0.05%)
Held by 1 FIIs (2.35%)
Rahim Ahmed Dawoodani (10.62%)
Devanshi Parimal Merchant (12.3%)
63.97%
Quarterly Results Snapshot (Standalone) - Dec'25 - YoY
YoY Growth in quarter ended Dec 2025 is -41.15% vs 0.39% in Dec 2024
YoY Growth in quarter ended Dec 2025 is -233.33% vs 200.00% in Dec 2024
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is -38.93% vs -1.45% in Sep 2024
Growth in half year ended Sep 2025 is -230.00% vs 131.25% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'25
YoY Growth in nine months ended Dec 2025 is -39.65% vs -0.87% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -231.25% vs 142.11% in Dec 2024
Annual Results Snapshot (Standalone) - Mar'25
YoY Growth in year ended Mar 2025 is -7.46% vs -32.49% in Mar 2024
YoY Growth in year ended Mar 2025 is 144.90% vs -117.75% in Mar 2024






